Opendata, web and dolomites

PainFACT SIGNED

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "PainFACT" data sheet

The following table provides information about the project.

Coordinator
FOLKEHELSEINSTITUTTET 

Organization address
address: LOVISENBERGGATA 8
city: OSLO
postcode: 456
website: www.fhi.no

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 7˙303˙046 €
 EC max contribution 6˙000˙000 € (82%)
 Programme 1. H2020-EU.3.1.1. (Understanding health, wellbeing and disease)
 Code Call H2020-SC1-2019-Two-Stage-RTD
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2024-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FOLKEHELSEINSTITUTTET NO (OSLO) coordinator 1˙342˙876.00
2    TATAA BIOCENTER AB SE (GOTEBORG) participant 1˙092˙453.00
3    UNIVERSITE DE STRASBOURG FR (STRASBOURG) participant 896˙000.00
4    ISLENSK ERFDAGREINING EHF IS (REYKJAVIK) participant 810˙000.00
5    OSLO UNIVERSITETSSYKEHUS HF NO (OSLO) participant 807˙750.00
6    UNIVERSIDAD POMPEU FABRA ES (BARCELONA) participant 800˙527.00
7    QUIBIM SOCIEDAD LIMITADA ES (VALENCIA) participant 250˙392.00

Map

 Project objective

Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression ─ also major contributors to disability, and with cardiovascular disease (CVD) and mortality. Twin studies indicate that these associations are a consequence of common causal mechanisms. The main objective of PainFACT is to identify these mechanisms. Using hypothesis-free genomic, proteomic, transcriptomic and brain-imaging discovery in available human studies and in a large cohort of outbred mice with multiple comorbidities, we aim to identify biomarkers that are associated across conditions. Predictive algorithms will be developed through machine learning techniques and tested in prospective analysis. Mendelian randomization approaches will be applied to test for causality. Mechanistic studies will be carried out in validated behavioral and atherosclerotic mouse models. Predictive markers will be tested as possible mediators of effects of lifestyle and obesity. Unique features of this program of research is the strong emphasis on experimental pain models and brain imaging techniques, facilitating translation of findings between mice and humans, and exploitation of the largest study of experimental pain worldwide and of multiple clinical datasets ranging in size from tens of thousands to 1.1 million. A custom protein panel will be developed together with sex and age stratified algorithms, with expected impact for the prediction and monitoring of disease and comorbidity, and for tracking effects of life-style changes. It is also expected that PainFACT results will have major impact on the diagnostic criteria and classification of affective disorders and CP. The identification of novel causal biomarkers will provide new targets for development of medicines and yield new insight into the causes of comorbidity.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PAINFACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PAINFACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.1.)

DC-ren (2020)

Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

Read More  

BIND (2020)

Brain Involvement iN Dystrophinopathies

Read More  

DECISION (2020)

DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

Read More